Evidence map›Paper›PMID 35930652›Full record

ArticleScience immunology2022

Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editing.

Michael K Okoreeh, Domenick E Kennedy, Akinola Olumide Emmanuel, Margaret Veselits, Azam Moshin, Robert H Ladd, Steven Erickson, Kaitlin C McLean, Brianna Madrigal, David Nemazee and 3 more

Open access · greenAbstract read
In one paragraph

Article in Science immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Computational and structural biotechnology journal · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Michael K OkoreehSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-7680-9488
Domenick E KennedySection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
Akinola Olumide EmmanuelSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-0118-7818
Margaret VeselitsSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-8755-6260
Azam MoshinSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-0021-3244
Robert H LaddCytometry and Antibody Technologies Facility, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-8047-8300
Steven EricksonDepartment of Pathology, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-5260-9286
Kaitlin C McLeanSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-4566-5105
Brianna MadrigalSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
David NemazeeDepartment of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.ORCID 0000-0002-4769-6311
Mark Maienschein-ClineCore for Research Informatics, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0001-6619-6788
Malay MandalSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-0451-3896
Marcus R ClarkSection of Rheumatology, Department of Medicine, University of Chicago, Chicago, IL 60637, USA.
University of Chicago · USUniversity of Illinois Chicago · USScripps Research Institute · US

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI KUNLE ODUNSI · 1985 to 2026
$122.1M
Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
MEDICAL SCIENTIST TRAININGT32GM007281 · NIGMS · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 1985 to 2022
$32.1M
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)T32HD007009 · NICHD · UNIVERSITY OF CHICAGO · PI NANCY B SCHWARTZ · 1985 to 2026
$13.0M
Role of CXCR4 in immunoglobulin light chain recombinationR01AI150860 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY, MANDAL, MALAY · 2021 to 2025
$2.9M
The epigenetic reader BRWD1 in peripheral adaptive immunityR01AI143778 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2019 to 2023
$2.4M
Regulation of Ig-kappa recombination during B lymphopoiesisR01AI120715 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2015 to 2019
$2.3M
BRWD1 in adaptive humoral immunityR21AI128785 · NIAID · UNIVERSITY OF CHICAGO · PI CLARK, MARCUS RAMSAY · 2017 to 2018
$444k
BRWD1 and the molecular regulation of humoral immunityF32AI143120 · NIAID · UNIVERSITY OF CHICAGO · PI KENNEDY, DOMENICK EDWARD · 2019 to 2020
$95k
NCATS NIH HHS UL1 TR002003NCI NIH HHS P30 CA014599NIAID NIH HHS F32 AI143120NIAID NIH HHS R01 AI120715NIAID NIH HHS R01 AI143778NIAID NIH HHS R01 AI150860NIAID NIH HHS R21 AI128785NICHD NIH HHS T32 HD007009NIGMS NIH HHS T32 GM007281
6 · The paper itself

Abstract

During B lymphopoiesis, B cell progenitors progress through alternating and mutually exclusive stages of clonal expansion and immunoglobulin (Ig) gene rearrangements. Great diversity is generated through the stochastic recombination of Ig gene segments encoding heavy and light chain variable domains. However, this commonly generates autoreactivity. Receptor editing is the predominant tolerance mechanism for self-reactive B cells in the bone marrow (BM). B cell receptor editing rescues autoreactive B cells from negative selection through renewed light chain recombination first at

Indexed as

B-LymphocytesReceptors, Antigen, B-CellAnimalsChromatinMiceRecombination, GeneticTranscription FactorsChromatinReceptors, Antigen, B-CellTranscription Factors

Identifiers

PMID35930652
PMCPMC9636592
OpenAlexW4290246343

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.